RELYPSA Trademark

Trademark Overview

On Wednesday, March 27, 2013, a trademark application was filed for RELYPSA with the United States Patent and Trademark Office. The USPTO has given the RELYPSA trademark a serial number of 85887902. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, March 16, 2023. This trademark is owned by Relypsa, Inc.. The RELYPSA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of hyperkalemia; pharmaceutical preparations for the treatment and prevention of renal, cardiovascular, and endocrine diseases or disorders; pharmaceutical preparations for reducing potassium levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of hyperkalemia and renal, cardiovascular, and endocrine disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of hyperkalemia and renal, cardiovascular, and endocrine disorders
relypsa

General Information

Serial Number85887902
Word MarkRELYPSA
Filing DateWednesday, March 27, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, March 16, 2023
Registration Number4909135
Registration DateTuesday, March 1, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of hyperkalemia; pharmaceutical preparations for the treatment and prevention of renal, cardiovascular, and endocrine diseases or disorders; pharmaceutical preparations for reducing potassium levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of hyperkalemia and renal, cardiovascular, and endocrine disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of hyperkalemia and renal, cardiovascular, and endocrine disorders
Translation of Words in MarkThe word(s) "RELYPSA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 1, 2013
Primary Code005
First Use Anywhere DateMonday, December 21, 2015
First Use In Commerce DateMonday, December 21, 2015

Trademark Owner History

Party NameRelypsa, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063
Party NameRelypsa, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063
Party NameRelypsa, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Trademark Events

Event DateEvent Description
Thursday, March 16, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, March 16, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, March 16, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 1, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, March 1, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 1, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, January 26, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, January 23, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, January 4, 2016STATEMENT OF USE PROCESSING COMPLETE
Monday, December 28, 2015USE AMENDMENT FILED
Monday, December 28, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, September 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 21, 2015SOU EXTENSION 2 GRANTED
Wednesday, September 9, 2015SOU EXTENSION 2 FILED
Friday, September 18, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 9, 2015TEAS EXTENSION RECEIVED
Thursday, June 18, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 18, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 11, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 9, 2015SOU EXTENSION 1 GRANTED
Monday, March 9, 2015SOU EXTENSION 1 FILED
Monday, March 9, 2015TEAS EXTENSION RECEIVED
Tuesday, September 9, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 25, 2014EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, March 25, 2014EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 11, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 11, 2014PUBLISHED FOR OPPOSITION
Wednesday, February 19, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 31, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 31, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 30, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 30, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 23, 2014ASSIGNED TO LIE
Thursday, January 9, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 9, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 9, 2013NON-FINAL ACTION E-MAILED
Tuesday, July 9, 2013NON-FINAL ACTION WRITTEN
Tuesday, July 9, 2013ASSIGNED TO EXAMINER
Monday, April 1, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 30, 2013NEW APPLICATION ENTERED

Related Keywords

relypsa pharmaceutical preparations prevention treatment cardiovascular disorders endocrine renal hyperkalemia namely